
News|Articles|March 1, 2004
Avastin (Bevacizumab) GENENTECH
First angiogenesis-inhibiting cancer therapy approved
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement























